Compass Pathways
Yahoo Finance • 20 days ago
Design Therapeutics Appoints Justin Gover to Board of Directors
CARLSBAD, Calif., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced the appointment of ind... Full story
Yahoo Finance • 2 months ago
Cathie Wood's ARK makes major moves in Trade Desk and Block stock
Cathie Wood’s ARK ETFs have once again made significant trades on Tuesday, 12 August 2025, with a major focus on tech and biotech stocks. The most substantial trade of the day was the purchase of 738,367 shares of Trade Desk Inc (NASDAQ:... Full story
Yahoo Finance • 2 months ago
Compass Pathways price target lowered to $40 from $45 at H.C. Wainwright
H.C. Wainwright lowered the firm’s price target on Compass Pathways (CMPS) to $40 from $45 and keeps a Buy rating on the shares. Compass confirmed that no further development is planned in anorexia nervosa following completion of the Phase... Full story
Yahoo Finance • 2 months ago
Cathie Wood's ARK ETFs shuffle RBLX, COIN, and BMNR stocks
Cathie Wood’s ARK ETFs have made significant moves in the stock market on Friday, August 1, 2025, with a particular focus on tech and biotech companies. Leading the trades was a massive purchase of Coinbase Global Inc (NASDAQ:COIN) share... Full story
Yahoo Finance • 2 months ago
COMPASS Pathways ADS Q2 2025 Earnings Preview
* COMPASS Pathways ADS (NASDAQ:CMPS [https://seekingalpha.com/symbol/CMPS]) is scheduled to announce Q2 earnings results on Thursday, July 31st, before market open. * The consensus EPS Estimate is -$0.37 [https://seekingalpha.com/symbo... Full story
Yahoo Finance • 3 months ago
Cathie Wood's ARK buys Tempus AI stock, sells Block and Roku
Cathie Wood’s ARK ETFs disclosed their daily trades for Wednesday, July 9th, 2025, with a significant focus on the tech and healthcare sectors. In the largest transaction of the day, ARK increased its position in Tempus AI Inc (NYSE:TEM),... Full story
Yahoo Finance • 3 months ago
Cathie Wood's ARK adjusts with Beam, Compass, and Komatsu trades
Cathie Wood’s ARK ETFs disclosed their daily trades for Thursday, 3rd July 2025, with a mix of buys and sells across various sectors. The most significant trade of the day involved the sale of KOMATSU LTD (TYO:6301) shares, with ARKX (NYSE... Full story
Yahoo Finance • 3 months ago
Cathie Wood's ARK ETFs buy Aerovironment, trim Roblox stock
Cathie Wood’s ARK ETFs have reported their daily trades for Wednesday, July 2nd, 2025, showcasing a mix of aggressive buys and strategic sells that may signal the firm’s shifting investment focus. The largest transaction of the day involve... Full story
Yahoo Finance • 3 months ago
Cathie Wood's ARK ETF adjusts portfolio, buys Tesla and ATAI stock
Cathie Wood’s ARK ETFs have made their latest round of daily trades on Tuesday, 01 July 2025, with significant activity across a variety of sectors. In a notable move, ARK has increased its holdings in Tesla Inc (NASDAQ:TSLA) with a substa... Full story
Yahoo Finance • 3 months ago
Global Neuro-Psychiatric Disorders & Treatment Market Projected to Reach $166 Billion by 2032
PALM BEACH, Fla., July 01, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Worldwide, there is a rising demand for neuropsychiatric disorder treatments which is expected to fuel the global markets for years to come. With expand... Full story
Yahoo Finance • 3 months ago
Compass Pathways stock holds Buy rating on positive depression trial
Investing.com - H.C. Wainwright maintained its Buy rating and $45.00 price target on Compass Pathways (NASDAQ:CMPS) following breakthrough clinical trial results for its psilocybin therapy. The global treatment-resistant depression market... Full story
Yahoo Finance • 3 months ago
Compass Pathways price target lowered to $7 by BTIG on drug concerns
Investing.com - BTIG lowered its price target on Compass Pathways (NASDAQ:CMPS) to $7.00 from $12.00 on Tuesday while maintaining a Buy rating, citing concerns about the company’s COMP360 drug development. For deeper insights into CMPS’s f... Full story
Yahoo Finance • 3 months ago
Tesla, Regencell lead market cap stock movers this Monday
Monday’s market has seen significant movements across various stocks, with companies like Tesla Motors (NASDAQ:TSLA) and Regencell Bioscience Holdings (RGC) experiencing notable changes. These intra-day stock movements are driven by a mi... Full story
Yahoo Finance • 3 months ago
Compass plummets as late-stage data on psychedelic asset for depression disappoints
[Microdosing concept.Dried psilocybin mushrooms Golden Teacher.Psychedelic Psilocybe Cubensis mushrooms. Medical use.Microdosing.] IURII BUKHTA/iStock via Getty Images Compass Pathways (NASDAQ:CMPS [https://seekingalpha.com/symbol/CMPS])... Full story
Yahoo Finance • 3 months ago
Tesla and AMD Lead Market Cap Stock Movers on Monday
Monday’s market has seen notable fluctuations among various stocks, particularly within the mega-cap and large-cap categories. Tesla Motors (NASDAQ:TSLA) and Advanced Micro Devices (NASDAQ:AMD) are experiencing significant rallies, while... Full story
Yahoo Finance • 3 months ago
I'll create a factual news article based on the press release in the Wall Street Journal style.
Compass reports positive Phase 3 results for psilocybin depression drug LONDON - Compass Pathways plc (NASDAQ:CMPS), a $433 million market cap biotech company currently rated as undervalued according to InvestingPro analysis, announced Mo... Full story
Yahoo Finance • 3 months ago
Oracle, JPMorgan Lead Market Cap Stock Movers on Wednesday
Wednesday’s trading session is showcasing significant movements across various market cap categories, with stocks like Oracle Corp (NYSE:ORCL) and JP Morgan Chase (NYSE:JPM) leading the gains in the mega-cap space, while Regencell Bios... Full story
Yahoo Finance • 2 years ago
25 Best Online Psychology Degree Programs Heading Into 2024
In this article, we will be looking at the 25 best online psychology degree programs heading into 2024. If you want to skip our detailed analysis, you can go directly to the 5 Best Online Psychology Degree Programs Heading Into 2024. Glob... Full story
Yahoo Finance • 2 years ago
Compass Pathways to participate in upcoming Evercore investor conference
LONDON, Nov. 24, 2023 (GLOBE NEWSWIRE) -- Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that management will hold a fi... Full story
Yahoo Finance • 2 years ago
Compass Pathways initiates UK component of global phase 3 study of psilocybin treatment in treatment-resistant depression and launches new research center
UK sites to participate in part of pivotal phase 3 program following Medicines and Healthcare Regulatory Agency approval of study Research will take place in the UK, including at the newly opened Centre for Mental Health Research and Inno... Full story
